Clinical

The combined date and time value recording when a drug concentration entry was created, modified, or captured in a pharmacy or clinical data system. Supports auditing, chronological tracking of medication strength changes, and time-based pharmacokinetic or therapeutic drug monitoring workflows.

The formal descriptive label assigned to a drug concentration record within a pharmacy or drug reference system. Provides a standardized name or heading identifying the strength entry, supporting drug compendium organization, formulary displays, medication order descriptions, and clinical documentation.

The complete aggregate sum of all drug concentration values calculated across components or measurements in a pharmaceutical record. Used in pharmacy data systems to represent the final combined strength of a formulation, supporting compounding calculations, dispensing verification, and medication management reporting.

The total number of discrete drug concentration occurrences or entries recorded within a pharmacy or medication data system. Used to quantify how many strength values are associated with a drug record, supporting formulary analysis, drug utilization reporting, and pharmaceutical data quality management.

A classification designating the category or nature of a drug concentration value, such as active ingredient strength, total strength, or base equivalent. Used in pharmacy and drug reference systems to distinguish between different strength representations within formulations, supporting accurate dispensing and clinical decision support.

The most recent date on which a drug concentration record was modified or revised within a pharmacy or formulary data system. Used to track changes to medication strength values over time, supporting data governance, formulary maintenance audits, and version control of pharmaceutical reference information.

A classification indicating the time sensitivity or clinical priority level associated with a drug concentration value or related medication event. Used in pharmacy and clinical data systems to flag situations requiring expedited processing, such as urgent compounding requests or critical therapeutic drug monitoring results.

The sequential version number assigned to a drug concentration record to track revisions over its lifecycle in a pharmacy or drug reference system. Enables identification of the most current strength specification while preserving historical values, supporting formulary change management and regulatory documentation requirements.

The postal code associated with a drug concentration record, typically referencing the geographic location of a pharmacy, compounding facility, or dispensing site. Used in pharmacy data systems to link strength records to specific locations for distribution tracking, regulatory compliance, and regional formulary management.

A binary flag indicating whether a diagnostic imaging study is currently active and accessible within a radiology or clinical data system. Used to distinguish active examinations from cancelled, archived, or superseded studies, supporting worklist management, PACS integration, and radiology workflow prioritization.

A status value representing the current operational state of a diagnostic imaging examination within a radiology information or clinical data system. Indicates whether the study is in progress, completed, on hold, or inactive, supporting imaging workflow management, reporting queues, and PACS record maintenance.

The date a patient was admitted to a healthcare facility in relation to a diagnostic imaging study, linking the examination to an inpatient encounter. Used in radiology and clinical data systems to associate imaging orders with hospital stays, supporting episode-of-care analysis and inpatient utilization reporting.

The patient's age at the time a diagnostic imaging study was performed, typically expressed in years. Captured in radiology and clinical data systems to support age-appropriate protocol selection, pediatric versus adult imaging distinctions, population health analysis, and epidemiological research based on imaging data.

The maximum reimbursable amount for a diagnostic imaging examination as determined by the payer contract or fee schedule. Represents the contracted rate ceiling used in radiology billing reconciliation, distinguishing between what was billed and what the payer will reimburse.

The total monetary value associated with a diagnostic imaging examination, capturing the gross charge before adjustments, discounts, or payer reductions. Used in radiology revenue cycle management to track financial transactions at the individual study level.

Identifies the credentialed user, typically a radiologist or supervising clinician, who authorized the diagnostic imaging examination. Used in radiology workflow audit trails to maintain accountability and regulatory compliance for study authorization and sign-off processes.

The recorded timestamp indicating when the patient physically arrived at the imaging facility or radiology department for their scheduled examination. Used in radiology operations to measure patient throughput, wait times, and scheduling efficiency metrics.

The calendar date on which the patient presented to the imaging facility for their diagnostic examination. Used in radiology scheduling and operations reporting to track appointment adherence, no-show patterns, and patient flow across imaging departments.

The radiologist's or interpreting clinician's structured clinical evaluation narrative for a diagnostic imaging examination. Captures findings, impressions, and conclusions derived from image interpretation, forming the core of the diagnostic radiology report.

The remaining unpaid financial obligation for a diagnostic imaging examination after insurance payments, adjustments, and partial payments have been applied. Used in radiology revenue cycle management to track outstanding patient or payer liability per individual study.